U.S. News
United States · Direct U.S. connection
NFL, Players Union Clash Over Jalen Hurts' Blood Clot Investigation
A public dispute emerged in late October 2026 between the NFL and the NFLPA regarding the handling of quarterback Jalen Hurts' blood clot diagnosis and a subsequent investigation.
Share this article
THE PRIMARY BRIEF
- 01 · The primary finding
The NFL Players Association called for a "full investigation" into the Philadelphia Eagles' handling of Jalen Hurts' blood clots after the NFL had indicated it would not review the care, prompting Commissioner Roger Goodell to state the league "welcomes" an investigation.
- 02 · The primary evidence
Jalen Hurts was medically cleared to play with a superficial blood clot found on October 10, 2026, but was later diagnosed with deep vein thrombosis and bilateral pulmonary emboli on October 19, 2026, after the clot moved.
- 03 · Why it matters
This public disagreement highlights differing perspectives on player medical safety and the transparency of league investigations, impacting trust between the NFL and its players.
The National Football League Players Association (NFLPA) called for a “full investigation” into the medical care of Philadelphia Eagles quarterback Jalen Hurts in late October 2026, after he was diagnosed with season-ending blood clots following a game he played with an initial clot diagnosis. This union demand contradicted earlier assurances from the NFL that it did not plan a review, prompting NFL Commissioner Roger Goodell to publicly state the league “welcomes” an investigation.
This conflict highlights differing views on player medical care and the transparency of league investigations. The back-and-forth between the league and its players' union surfaces questions about accountability in high-stakes sports medicine decisions and could impact future safety protocols for professional athletes.
What the records show
On October 10, 2026, an ultrasound identified a superficial blood clot in Jalen Hurts' calf while the Philadelphia Eagles were in London. Despite this finding, Hurts received medical clearance to play in the team's Week 5 game against the Jacksonville Jaguars on October 11, 2026. Following the game and the team's return from London, a subsequent ultrasound revealed that the blood clot had moved. Further testing and monitoring led to a joint statement from the Philadelphia Eagles and Hurts' agent, Nicole Lynn, on October 19, 2026. This statement confirmed a diagnosis of deep vein thrombosis and bilateral pulmonary emboli, meaning blood clots had traveled to his lungs. Hurts was subsequently placed on injured reserve and is expected to miss the remainder of the season, requiring treatment with blood thinners. Multiple media outlets reported that the NFL would not discipline the Eagles for their handling of Hurts' medical issue.
The timeline
- October 10, 2026: An ultrasound in London reveals a superficial blood clot in Jalen Hurts' calf. He is medically cleared to play.
- October 11, 2026: Hurts plays in the Eagles' Week 5 game against the Jacksonville Jaguars.
- Prior to October 20, 2026: The NFLPA asserts the NFL previously informed the union it did not intend to review Hurts' medical care.
- October 19, 2026: The Philadelphia Eagles and Hurts' agent, Nicole Lynn, confirm Hurts' diagnosis of deep vein thrombosis and bilateral pulmonary emboli. Hurts is placed on injured reserve.
- October 20, 2026: Dr. Allen Sills, the NFL's chief medical officer, publicly defends the Eagles' medical staff. The NFLPA issues a statement calling for a “full investigation”.
- October 21, 2026: NFL Commissioner Roger Goodell states the league “welcomes” an investigation into the Eagles' handling of Hurts' blood clots.
What changed and for whom
The NFLPA initially claimed the NFL stated it would not review Hurts' care. This changed after the union's public call for a “full investigation”. Commissioner Roger Goodell then affirmed the league “welcomes” such a review, indicating a shift from a position of no planned review to an openness for scrutiny. For Jalen Hurts, his condition progressed from a superficial calf clot to deep vein thrombosis and bilateral pulmonary emboli, resulting in his placement on injured reserve for the season. The Eagles will continue the season without their starting quarterback.
What the subject has said publicly
On October 20, 2026, Dr. Allen Sills, the NFL's chief medical officer, defended the Eagles' medical staff. Sills stated, “the notion that there's external factors that any of our physicians would put a player in harm's way, that's nonsense”. He also said that speculating on medical decisions without all the data is “unprofessional and unethical”. Sills noted that the league tracks blood clot cases every season and shares data with the players' association.
On October 21, 2026, Commissioner Roger Goodell affirmed the league's position, stating, “Our protocols were incredibly good there” and “The protocols were followed” regarding Hurts' medical evaluation. Goodell also downplayed the impact of international travel on Hurts' condition, emphasizing that “The most important thing here is Jalen's health”. NFL Executive Vice President Jeff Miller refuted earlier media reports about Hurts' sleep before the London game, clarifying that Hurts slept for approximately seven or eight hours.
What we could not confirm
We could not confirm the exact nature or scope of any investigation the NFL might undertake following its expressed welcome for a review. We also could not confirm the specifics of the “external factors” Dr. Sills dismissed regarding player safety, or the exact media reports Jeff Miller refuted about Hurts' sleep schedule prior to the London game.
SHOW YOUR WORK